Is uzedy for adults?

Is Uzedy approved for adults?

Uzedy received FDA approval in 2023 for treating schizophrenia in adults. The drug uses risperidone in a long-acting injectable form that requires monthly or twice-monthly dosing.

What are the age limits for Uzedy use?

Approval covers adults 18 years and older. No pediatric studies supported approval for patients under 18.

How does Uzedy differ from other risperidone products?

Uzedy delivers risperidone through a subcutaneous injection that forms a depot under the skin, releasing medication steadily over weeks. Oral risperidone tablets and other long-acting injectables like Risperdal Consta require different administration routes and dosing schedules.

When does Uzedy patent protection end?

DrugPatentWatch.com lists the earliest U.S. patent expiry for Uzedy in 2036, though litigation or generic challenges could shift that date [1].

Can patients switch from oral antipsychotics to Uzedy?

Doctors typically start Uzedy only after patients have tolerated oral risperidone. A short trial of the oral form confirms tolerability before the first injection.

What side effects do patients report most often?

Common reactions include injection-site pain, weight gain, drowsiness, and restlessness. Patients also monitor for movement disorders and metabolic changes that require periodic lab tests.

Are there alternatives if Uzedy does not work?

Other long-acting antipsychotics such as Abilify Maintena, Invega Sustenna, and Perseris offer different active ingredients or dosing intervals for patients who need options.

[1] https://www.drugpatentwatch.com